Factor Xa - a promising target for drug development

被引:43
作者
Kaiser, B [1 ]
机构
[1] Univ Jena, Ctr Vasc Biol & Med Erfurt, D-99089 Erfurt, Germany
关键词
D O I
10.1007/s00018-002-8415-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:189 / 192
页数:4
相关论文
共 40 条
  • [1] Factor Xa inhibitors
    Al-Obeidi, F
    Ostrem, JA
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (07) : 931 - 953
  • [2] ALTIERI DC, 1994, J BIOL CHEM, V269, P3139
  • [3] ALTIERI DC, 1990, J IMMUNOL, V145, P246
  • [4] BAUER K, 2001, THROMB HAEMOST S, pOC46
  • [5] Recent advances in Factor Xa inhibitors
    Betz, A
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (06) : 1007 - 1017
  • [6] Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF
    Blanc-Brude, OP
    Chambers, RC
    Leoni, P
    Dik, WA
    Laurent, GJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 281 (02): : C681 - C689
  • [7] STRUCTURE-ACTIVITY RELATIONSHIP IN HEPARIN - A SYNTHETIC PENTASACCHARIDE WITH HIGH-AFFINITY FOR ANTI-THROMBIN-III AND ELICITING HIGH ANTI-FACTOR-XA ACTIVITY
    CHOAY, J
    PETITOU, M
    LORMEAU, JC
    SINAY, P
    CASU, B
    GATTI, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 116 (02) : 492 - 499
  • [8] A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction - The PENTALYSE study
    Coussement, PK
    Bassand, JP
    Convens, C
    Vrolix, M
    Boland, J
    Grollier, G
    Michels, R
    Vahanian, A
    Vanderheyden, M
    Rupprecht, HJ
    Van de Werf, F
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (18) : 1716 - 1724
  • [9] DEPASSE F, 2001, THROMB HAEMOST S, pP3098
  • [10] Mechanism of heparin activation of antithrombin:: Evidence for an induced-fit model of allosteric activation involving two interaction subsites
    Desai, UR
    Petitou, M
    Björk, I
    Olson, ST
    [J]. BIOCHEMISTRY, 1998, 37 (37) : 13033 - 13041